REPLIGEN CORP Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- REPLIGEN CORP stock issued during period, value, stock options exercised for fiscal 2014 was $1.68M, a 33.37% decline from fiscal 2013.
- REPLIGEN CORP stock issued during period, value, stock options exercised for fiscal 2013 was $2.52M, a 117.61% increase from fiscal 2012.
- REPLIGEN CORP stock issued during period, value, stock options exercised for fiscal 2012 was $1.16M, a 4636156.00% increase from fiscal 2011.
- REPLIGEN CORP stock issued during period, value, stock options exercised for fiscal 2011 was $25.00.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2014-12-31 | $1.68M 10-K · filed 2015-03-17 | |
| 2013-12-31 | $2.52M 10-K · filed 2015-03-17 | |
| 2012-12-31 | $1.16M 10-K · filed 2015-03-17 | |
| 2011-12-31 | $25.00 10-K · filed 2014-03-14 | |
| 2011-03-31 | $6.57K 10-K · filed 2013-03-15 | |
| 2010-03-31 | $53.99K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |